osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis
March 2009
You'll hear more controversy about osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis.
This destruction of the jaw bone was initially seen in patients on high doses of IV bisphosphonates for cancer.
The incidence with ORAL bisphosphonates is much lower... probably less than 0.1%.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive